Head-to-Head

ABBVIE INC. vs. Eton Pharmaceutcials, Inc. Common Stock

ABBV

ABBVIE INC.

$250.33 +0.35%

VS ETON

Eton Pharmaceutcials, Inc. Common Stock

$61.73 +4.88%

ABBVIE INC. (ABBV) comes out ahead, leading on 5 of 8 compared factors.

Size & Scale

ABBVETON
Market Cap $440.83 billion $1.68 billion
Revenue (TTM) $64.39 billion $105.59 million
Net Income (TTM) $6.32 billion $12.69 million

ABBV leads on 3 of 3 size & scale factors.

Valuation

ABBVETON
P/E Ratio 70.71 —
Price / Book -74.87 36.11
Price / Sales 6.85 15.93

ABBV leads on 2 of 2 valuation factors.

Profitability

ABBVETON
Net Margin 9.81% 12.02%
Return on Equity -107.29% 27.24%

ETON leads on 2 of 2 profitability factors.

Dividend

ABBVETON
Dividend Yield 2.76% —
Payout Ratio 195.48 —

ABBV and ETON split the dividend factors evenly.

Risk & Sentiment

ABBVETON
Short Interest 0.85% 0.21%

ETON leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, ETON overview, ETON financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.